What do we know about Immunity to SARS-CoV-2? Implications for Public Health Policies

Vista senzilla d'ítem
dc.contributor.authorBlanco Arbués, Julià
dc.contributor.authorSarukhan, Adelaida
dc.contributor.authorDíez Antón, Juana, 1962-
dc.contributor.authorBassat Orellana, Quique
dc.contributor.authorCampins Martí, Magda
dc.contributor.authorGüerri Fernández, Robert
dc.contributor.authorBrotons, Carlos
dc.contributor.authorSans Corrales, Mireia
dc.contributor.authorMiró Meda, José M. (José María), 1956-
dc.contributor.authorSanjosé Llongueras, Silvia de
dc.date.accessioned2021-02-24T11:30:18Z
dc.date.available2021-02-24T11:30:18Z
dc.date.issued2021-02-24
dc.descriptionAdditional support from ISGlobal’s Antoni Plasència and Josep M. Antó
dc.description.abstractAs the COVID-19 pandemic progresses, so does our knowledge of the magnitude, type and durability of the immune response to SARS-CoV-2 as a result of natural infection or vaccination. This information is crucial since it will largely define the strategies we need to implement in order to protect individuals and populations. With this in mind, the GCMSC presents its second report, where they review the current knowledge on immunity to SARS-CoV-2 and the implications in terms of public health policies.ca
dc.format.extent37 p.
dc.format.mimetypeapplication/pdf
dc.identifier.urihttps://hdl.handle.net/2445/174239
dc.language.isoengca
dc.publisherInstitut de Salut Global de Barcelona (ISGlobal)ca
dc.publisherCol·legi Oficial de Metges de Barcelona (COMB)
dc.rightscc-by (c) Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC), 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceDocuments de treball / Informes (ISGlobal)
dc.subject.classificationCOVID-19
dc.subject.classificationVacunes
dc.subject.classificationImmunitat
dc.subject.classificationSalut pública
dc.subject.otherCOVID-19
dc.subject.otherVaccines
dc.subject.otherImmunity
dc.subject.otherPublic health
dc.titleWhat do we know about Immunity to SARS-CoV-2? Implications for Public Health Policiesca
dc.typeinfo:eu-repo/semantics/reportca

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Miniatura
Nom:
Report Immunity to SARS CoV2.pdf
Mida:
668.98 KB
Format:
Adobe Portable Document Format
Descarregar

Col·leccions

Documents de treball / Informes (ISGlobal)